RNAi FORMULATION FOR INHIBITING PCSK9 GENE EXPRESSION AND USE THEREOF
AssigneeMabwell (Shanghai) Bioscience Co., Ltd.
InventorsFuzheng Yang, Hao Chen, Bing Jin, Denghui Hu, Chengxin Ma, Xun Gui
Life of this patent
Estimating the term…
Loading patent…
AssigneeMabwell (Shanghai) Bioscience Co., Ltd.
InventorsFuzheng Yang, Hao Chen, Bing Jin, Denghui Hu, Chengxin Ma, Xun Gui
Estimating the term…
The present application provides an RNA inhibitor for inhibiting PCSK9 gene expression, which comprises an antisense strand, wherein the antisense strand comprises a complementary region that is complementary to at least a part of an mRNA encoding PCSK9, and the complementary region is 17-23 nucleotides in length. The antisense strand comprises the following nucleotide sequence: any one of SEQ ID NOs: 328-654, 1045-1107, 1125-1146, or 1149-1170, or a sequence differing by no more than 3 nucleotides therefrom. In addition, the present application also provides a pharmaceutical composition, which comprises the RNA inhibitor for inhibiting PCSK9 gene expression, and further comprises a delivery vehicle, and/or a physiologically acceptable excipient and/or carrier and/or diluent.
1-65. (canceled)
An siRNA molecule that targets PCSK9, wherein the siRNA molecule comprises a sense strand comprising the nucleobase sequence of SEQ ID NO:
A composition comprising a first siRNA molecule and a second siRNA molecule, wherein the first siRNA molecule targets PCSK9 and comprises a sense strand comprising the nucleobase sequence of SEQ ID NO:
A composition comprising:
Dependencies are inferred from the claim text.